Navigation Links
Nektar Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/4/2010

, clinical outcomes, competitive factors, or delay or failure in ultimately obtaining regulatory approval in one or more important markets; (iii) scientific discovery of new medical breakthroughs is an inherently uncertain process and the future success of the application of Nektar's technology platforms to potential new drug candidates is therefore very uncertain and unpredictable and one or more research and development programs could fail; (iv) Nektar's patent applications for its proprietary or partner product candidates may not issue, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required in the future; (v) the outcome of any future intellectual property or other litigation related to Nektar's proprietary product candidates or complex commercial agreements; (vi) if Nektar is unable to establish and maintain collaboration partnerships on attractive commercial terms (such as for NKTR-102), our business, results of operations and financial condition could suffer; and (vii) certain other important risks and uncertainties set forth in Nektar's Quarterly Report on Form 10-Q for the quarter ended June 30, 2010 filed with the SEC on July 28, 2010, the Current Report on Form 8-K filed with the SEC today, and the Quarterly Report on Form 10-Q for the quarter ended September 30, 2010 to be filed with the SEC on or about November 4, 2010.  Actual results could differ materially from the forward-looking statements contained in this press release.  Nektar undertakes no obligation to update forward-looking statements, whether as a result of new information, future events or otherwise.

Nektar Investor Inquiries:Jennifer Ruddock/Nektar Therapeutics(650) 631-4954Susan Noonan/SA Noonan Communications, LLC(212) 966-3650Nektar Media Inquiries: Karen Bergman/BCC Partners(650) 575-1509 Michelle Corral/BCC Partners(415) 794-866
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
2. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
3. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
6. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
8. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
11. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... DUBLIN , June 24, 2015 ... has announced the addition of the "2015 ... to their offering. This new 175-page ... market segments, including diabetes (strips and meters), pregnancy, ... dynamics, size, growth, regulatory requirements, technologies, and competitive ...
(Date:7/1/2015)... July 1, 2015  Unilife Corporation (NASDAQ: UNIS ... of injectable drug delivery systems, announced today that its ... June 30, 2015. This amendment removed a covenant that ... cash receipts from customers during the six months ended ... any of the terms of the debt agreement as ...
(Date:7/1/2015)... 1, 2015  MEI Pharma, Inc. (Nasdaq: MEIP ), ... therapies for cancer, announced today that Daniel P. Gold ... the inaugural Cantor Fitzgerald Healthcare Conference on Wednesday, July 8, ... Meridien in New York . A ... www.meipharma.com . A replay will be available approximately one hour ...
Breaking Medicine Technology:2015 Strategies in the Home/Self Testing Market 2Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference 2
... , , DURHAM, N.C. , ... expanding contract developer and manufacturer of prescription pharmaceutical products, ... China .  This new facility will expand Gorbec,s current ... taking this action to better serve its U.S. customer ...
... , CARLSBAD, Calif. , Feb. 4 ... services, announced today that it expects to report its financial results for ... Select Market on Thursday, February 25, 2010 . , A ... Ph.D., and other members of senior management will take place on the ...
Cached Medicine Technology:Gorbec Pharmaceutical Services, Inc. Announces the Launch of Its GMP Analytical Laboratory in China 2Genoptix, Inc. to Announce Fourth Quarter and Full-Year 2009 Financial Results 2Genoptix, Inc. to Announce Fourth Quarter and Full-Year 2009 Financial Results 3
(Date:7/1/2015)... ... 01, 2015 , ... The 28th annual Charity Horse Show hosted by the ... at 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. The event will again ... an Elvis impersonator, a silent auction and concessions. , Horses and riders from around ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Convoy ... a community celebration in the Twin Cities on Saturday, August 1, at Spring Lake ... Cities community will provide more than $1 million worth of goods and services including ...
(Date:7/1/2015)... ... 01, 2015 , ... RowdMap Inc. is a proud participant ... “Pro-actively Identifying the High-Cost Patient Population: Insights from the Health Care Transformation Task ... http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task Force is a group of private ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Franklin University, one ... Dr. Leslie King has been named Dean of the College of ... Dr. King will promote and support the vision and mission of Franklin University via ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... summer sale. Customers purchasing two or more Bunion Booties directly from their ... , Bunion Bootie temporarily corrects misaligned toes and its ultra thin properties allow ...
Breaking Medicine News(10 mins):Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:Franklin University Appoints Dean of College of Health & Public Administration 2Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2
... organs in every brachytherapy procedure should be carefully analyzed ... every patient, according to a new guideline co-authored by ... department of Radiation Oncology at Thomas Jefferson University. ... by the American Association of Physicists in Medicine (AAPM), ...
... behavior, study finds, , MONDAY, Nov. 2 (HealthDay News) ... is linked to aggression in young children. , This ... Archives of Pediatrics & Adolescent Medicine , found that ... indirect viewing in the household were both associated with ...
... ... care legislation pending in Congress, Americans are anxious to see how the ... with reform and advances in medicine on the horizon, nearly 1.5 million ... 50 Million Pound Challenge, which announced this week the loss of its ...
... ... statement on prostate cancer testing, clarifying the Association,s recommendations and support of early detection. ... (Vocus) November ... disparaging prostate cancer testing. We are concerned that these reports are causing significant confusion ...
... 2 IPC The Hospitalist Company, Inc. (Nasdaq: IPCM ... financial results for the third quarter ended September 30, 2009. ... 2008): , Net revenue increased 23% to $77.5 million, ... encounters increased 19% to 823,000 Income from operations rose ...
... Nov. 2 comScore, Inc. (Nasdaq: ... and ImpactRx, a pharmaceutical insights company, today announced the ... only digital measurement solution that connects physicians, online and ... solution is carefully designed to comply with health privacy ...
Cached Medicine News:Health News:Task force develops new radiation guidelines for brachytherapy 2Health News:TV May Increase Aggression in Toddlers 2Health News:TV May Increase Aggression in Toddlers 3Health News:America Battles Obesity, Dropping 5 Million Pounds 2Health News:America Battles Obesity, Dropping 5 Million Pounds 3Health News:AUA Releases Statement Clarifying Prostate Cancer Testing Recommendations 2Health News:AUA Releases Statement Clarifying Prostate Cancer Testing Recommendations 3Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 2Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 3Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 4Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 5Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 6Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 7Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 8Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 9Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 10Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 11Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 12Health News:IPC The Hospitalist Company Reports Third Quarter 2009 Results 13Health News:comScore Announces Availability of comScore/ImpactRx Physician Behavioral Measurement(TM) Solution 2Health News:comScore Announces Availability of comScore/ImpactRx Physician Behavioral Measurement(TM) Solution 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: